Examiner Andrew R. Millikin
Grant ratio: 60.8% (25th percentile in Art Unit 2832 among examiners with at least 20 applications). Average office actions per grant: 2.00. Most common rejection type: §103.
Appears inactive
Last office action in data: August 2012
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 2 | 65.2% | 1.55 |
| Group | 358 | 65.8% | 1.58 |
| Tech Center | 2,435 | 61.3% | 1.69 |
| USPTO | 16,620 | 51.8% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 59 | 45.4% |
| 2 OAs | 40 | 30.8% |
| 3 OAs | 19 | 14.6% |
| 4 OAs | 7 | 5.4% |
| 5+ OAs | 5 | 3.8% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2008 | 19 | 8 | 42.1% |
| 2009 | 48 | 29 | 60.4% |
| 2010 | 26 | 16 | 61.5% |
| 2011 | 35 | 24 | 68.6% |
| 2012 | 2 | 2 | 100.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 130 | 0.8% | 23.1% | 62.3% | 13.1% |
| Action 2 | 71 | 0.0% | 21.1% | 69.0% | 8.5% |
| Action 3 | 31 | 0.0% | 12.9% | 74.2% | 12.9% |
| Action 4 | 12 | 0.0% | 16.7% | 66.7% | 16.7% |
| Action 5 | 5 | 0.0% | 20.0% | 80.0% | 0.0% |
| Action 6 | 4 | 0.0% | 25.0% | 75.0% | 0.0% |
| Action 7 | 1 | 0.0% | 100.0% | 0.0% | 0.0% |
| Action 8 | 1 | 0.0% | 100.0% | 0.0% | 0.0% |
Section 101 rejections
Last 3 years: 2023-10-23–2026-10-23. All years includes every dated office action in the data.
By year
1.5%
0.0%
0.0%
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Oct. 30, 2026.